NADAL COVID-19 IgG/IgM Test

The NADAL COVID-19 IgG/IgM Test is a rapid, reliable, and easy-to-use lateral flow immunoassay designed to detect IgG and IgM antibodies against SARS-CoV-2 in human whole blood, serum, or plasma samples. Ideal for point-of-care diagnostics, this test provides results within 10–15 minutes, supporting early detection of past or recent COVID-19 infections. It helps healthcare professionals assess immune response and track virus exposure in individuals. With its high sensitivity and specificity, the NADAL COVID-19 antibody test is a valuable tool in clinical diagnostics, epidemiological studies, and mass screening programs. CE-marked and validated under strict quality standards, it ensures dependable performance in professional healthcare settings.